All research
Semaglutide 2026-06 ClinicalTrials

Brown Adipose Tissue Activity Explored as a Predictor for Semaglutide Weight Loss Response in Obesity

Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)

Abstract

This ongoing study investigates if baseline brown adipose tissue (BAT) activity can predict individual weight loss and metabolic improvement in response to semaglutide treatment for obesity.


Source: clinicaltrials:NCT07621640 · Ingested 2026-06-29 · Digest: gemini-2.5-flash